 Reversibility blue-gray cutaneous discoloration amiodarone man severe blue-gray cutaneous discoloration amiodarone therapy atrial fibrillation drug regimen long-term anticoagulation digoxin therapy patient exposure skin bleaching agent months follow-up blue-gray hyperpigmentation photosensitivity reactions amiodarone occur patients blue-gray cutaneous discoloration patients prolonged therapy amiodarone presence high concentrations iodine electron probe analysis cutaneous deposits amiodarone metabolite slow rate elimination amiodarone high uptake fat-associated tissues delayed disappearance cutaneous photosensitivity late resolution blue-gray discoloration current case reversibility adverse effects long-term follow-up